Evidence map›Paper›PMID 25589269›Full record

ReviewComprehensive Physiology2015

Neural control of the circulation: how sex and age differences interact in humans.

Michael J Joyner, Jill N Barnes, Emma C Hart, B Gunnar Wallin, Nisha Charkoudian

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Comprehensive Physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03775096 phase2active not recruitingnot on this mapstarted 2019, after this paper: background citation

The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease

TypeinterventionalSponsorMichele Tagliati, MDRan2019 to 2026Enrolled15ConditionsREM Sleep Behavior Disorder, Pre-motor Parkinson Disease, Symptomatic Parkinson DiseaseArmsCarvedilol
NCT05109364 phase2active not recruitingnot on this mapstarted 2022, after this paper: background citation

The Effect of alpha1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up Study

TypeinterventionalSponsorCedars-Sinai Medical CenterRan2022 to 2026Enrolled15ConditionsSymptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's DiseaseArmsTerazosin therapy
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Peripheral chemoreflex inhibition with low-dose dopamine: new insight into mechanisms of extreme apnea.American journal of physiology. Regulatory, integrative and comparative physiology · 2015
    Trial
  6. Article
  7. Article
  8. Comparison of Heart Rate Variability Between Sexes: Impact of a Physically Active Lifestyle.International journal of environmental research and public health · 2026
    Article
  9. Review
  10. Machine Learning Insights into Age-Related Sex Differences in Blood Pressure: Influence of Diabetes and Body Mass Index.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Relationship between resting augmentation index and spontaneous cardiac baroreflex sensitivity during handgrip exercise in postmenopausal women.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  19. Article
  20. Revisiting sex as a biological variable in hypertension research.The Journal of clinical investigation · 2024
    Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Michael J JoynerDepartment of Anesthesiology, Mayo Clinic, Rochester, Minnesota.
Jill N BarnesSchool of Physiology and Pharmacology, University of Bristol, Bristol, United Kingdom.
Emma C HartInstitute of Neuroscience and Physiology, The Sahlgren Academy at Gothenburg University, Gothenburg, Sweden.
B Gunnar WallinThermal and Mountain Medicine Division, US Army Research Institute of Environmental Medicine, Natick, Massachusetts.
Nisha CharkoudianThermal and Mountain Medicine Division, US Army Research Institute of Environmental Medicine, Natick, Massachusetts.
U.S. Army Research Institute of Environmental Medicine · USMayo Clinic · USUniversity of Bristol · GBUniversity of Gothenburg · SE

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Neurovascular Control and Blood Pressure Regulation in HumansR01HL083947 · NHLBI · MAYO CLINIC ROCHESTER · PI JOYNER, MICHAEL J · 2007 to 2016
$3.6M
Brain Vasodilator Responses in Healthy and Cognitively Impaired HumansF32AG038067 · NIA · MAYO CLINIC ROCHESTER · PI BARNES, JILL NICOLE · 2011 to 2012
$69k
British Heart Foundation FS/11/1/28400NCATS NIH HHS UL1 TR000135NHLBI NIH HHS HL-83947NHLBI NIH HHS R01 HL083947NIA NIH HHS AG 38067NIA NIH HHS F32 AG038067
6 · The paper itself

Abstract

The autonomic nervous system is a key regulator of the cardiovascular system. In this review, we focus on how sex and aging influence autonomic regulation of blood pressure in humans in an effort to understand general issues related to the cardiovascular system as a whole. Younger women generally have lower blood pressure and sympathetic activity than younger men. However, both sexes show marked interindividual variability across age groups with significant overlap seen. Additionally, while men across the lifespan show a clear relationship between markers of whole body sympathetic activity and vascular resistance, such a relationship is not seen in young women. In this context, the ability of the sympathetic nerves to evoke vasoconstriction is lower in young women likely as a result of concurrent β2-mediated vasodilation that offsets α-adrenergic vasoconstriction. These differences reflect both central sympatho-inhibitory effects of estrogen and also its influence on peripheral vasodilation at the level of the vascular smooth muscle and endothelium. By contrast postmenopausal women show a clear relationship between markers of whole body sympathetic traffic and vascular resistance, and sympathetic activity rises progressively in both sexes with aging. These major findings in humans are discussed in the context of differences in population-based trends in blood pressure and orthostatic intolerance. The many areas where there is little sex-specific data on how the autonomic nervous system participates in the regulation of the human cardiovascular system are highlighted.

Indexed as

AgingAutonomic Nervous SystemBlood PressureCardiovascular Physiological PhenomenaFemaleGonadal Steroid HormonesHumansMaleSex CharacteristicsGonadal Steroid Hormones

Identifiers

PMID25589269
PMCPMC4459710
OpenAlexW1543527640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.